Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling PathwayDongmei Qin(Xiamen University), Jie Zha(Xiamen University)International Journal of Biological SciencesAugust 22, 202510.7150/ijbs.116437Cited by 2SaveCiteExport RISWatch citationsRelated PapersBcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia|Cell Death and Disease|2023|14Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma|Clinical Epigenetics|2025|1Anlotinib Induced Venetoclax-resistant Acute Myeloid Leukemia Stem Cells Apoptosis through Downregulating Mcl-1-mediated Anti-apoptoeic Pathway|Research Square|2025|0